2022-502620-49-00CompletedPhase 1

A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV Melanoma in the Adjuvant Setting

Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Dec 2025

Next steps

Status (registry): Completed
Phase (registry): Phase 1
Study type: Interventional
Enrollment: 156 (actual)
First submitted: 23 Feb 2023
Start date: 1 Aug 2023
Lead sponsor: Amgen Inc.
Diseases: Melanoma
EU CT number: 2022-502620-49-00

What you commit to

Study type: Interventional · Phase 1
Participants enrolled: 156
39 sites in 8 countries
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (39)

Sites in registry order. Save your city in your profile to sort them by distance.

Site	City	Country	Site status
Charite Universitaetsmedizin Berlin KöR	Berlin	Germany	Completed
University Hospital Cologne AöR	Cologne	Germany	Completed
Goethe University Frankfurt	Frankfurt Am Main	Germany	Completed
SRH Wald-Klinikum Gera GmbH	Gera	Germany	Completed
University Medical Center Hamburg-Eppendorf	Hamburg	Germany	Completed
Catalan Institute of Oncology	Badalona	Spain	Completed
Hospital de la Santa Creu i Sant Pau	Barcelona	Spain	Completed
Hospital Universitari Vall d'Hebron	Barcelona	Spain	Completed
Hospital Clinic de Barcelona	Barcelona	Spain	Completed
Hospital San Pedro De Alcántara	Cáceres	Spain	Completed
Hospital Jerez Puerta Del Sur Grupo Hla S.A.	Jerez De La Frontera	Spain	Completed
MD Anderson Cancer Center	Madrid	Spain	Completed
University Clinical Hospital Virgen De La Arrixaca	Murcia	Spain	Completed
Hospital Universitario Virgen De La Macarena	Sevilla	Spain	Completed
Hospital General Universitario de Valencia	Valencia	Spain	Completed
CHU De Bordeauxt	Bordeaux Cedex	France	Completed
Hôpital Ambroise-Paré	Boulogne-Billancourt	France	Completed
Centre Hospitalier Universitaire de Dijon	Dijon	France	Completed
Centr Georges Francois Leclerc	Dijon	France	Completed
Centre Hospitalier Universitaire De Lille	Lille Cedex	France	Completed
Centre Hospitalier Universitaire de Poitiers	Poitiers	France	Completed
Klinicki bolnicki centar Sestre milosrdnice	Grad Zagreb	Croatia	Completed
University Hospital Centre Zagreb	Grad Zagreb	Croatia	Completed
Azienda Ospedaliero-Universitaria delle Marche	Ancona	Italy	Completed
Istituto Tumori Bari Giovanni Paolo II	Bari	Italy	Completed
Azienda Ospedaliera Papa Giovanni XXIII	Bergamo	Italy	Completed
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l	Meldola	Italy	Completed
Ospedale San Raffaele S.r.l.	Milan	Italy	Completed
European Institute Of Oncology S.r.l.	Milan	Italy	Completed
Azienda Ospedaliera Universitaria Federico II Di Napoli	Naples	Italy	Completed
Fondazione IRCCS Policlinico San Matteo	Pavia	Italy	Completed
Fondazione Policlinico Universitario Campus Bio-Medico	Rome	Italy	Completed
Fondazione Luigi Maria Monti	Rome	Italy	Completed
Azienda Ospedaliera Universitaria Senese	Siena	Italy	Completed
Azienda Ospedaliera Ospedale Di Circolo E Fondazione Macchi	Varese	Italy	Completed
Nacionalinis Vezio Institutas	Vilnius	Lithuania	Completed
Amphia Hospital	Breda	Netherlands	Completed
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti	Bucharest	Romania	Completed
Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca	Cluj-Napoca	Romania	Completed

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.